ECVT · Ecovyst Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 5, 2026TL;DR. Ecovyst reported Q2 2026 sales of $250 million (+42% YoY) and adjusted EBITDA of $53.1 million (+27% YoY), completed the Calabrian acquisition on June 30, and raised full-year 2026 adjusted EBITDA guidance to $195–$207 million from $180–$195 million, including expected Calabrian contributions.
- + Raised full-year 2026 adjusted EBITDA guidance to $195–$207 million (from $180–$195 million) on stronger legacy results and Calabrian contribution.
- + Raised full-year 2026 adjusted free cash flow guidance to $45–$55 million (from $40–$55 million) and adjusted EPS to $0.58–$0.72 (from $0.50–$0.65).
- + H1 2026 adjusted free cash flow of $12.8 million swung positive from $(2.4) million a year ago.
- − Net debt leverage ratio rose to 2.0x from 1.2x at year-end 2025 due to $100 million acquisition debt with no trailing Calabrian EBITDA.
- − Cautious near-term outlook for virgin sulfuric acid volumes into industrial applications and risk of destocking if sulfur prices ease.
- − Capital expenditures guidance raised to $85–$95 million from $80–$90 million, reflecting Gulf Coast expansion and Calabrian.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ECVT
this stock
Ecovyst Inc.
|
$1.11B | +2.4% | +20.9% | — | 4.8% |
|
LIN
Linde PLC
|
$216.61B | +10.1% | +3.0% | 30.3 | 1.3% |
|
AIQUF
L Air Liquide SA /Fi
|
$121.25B | -1.1% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$79.89B | -1.0% | +2.1% | 30.4 | 2.6% |
|
ECL
Ecolab Inc.
|
$78.35B | +3.3% | +2.2% | 37.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ECVT | -1.8% | -4.0% | -28.5% | +1.3% | +2.4% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | -1.4% | -3.8% | -40.9% | +1.1% | -9.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.